RJA
HCM icon

Raymond James & Associates’s HUTCHMED HCM Stock Holding History

Raymond James & Associates’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,288
Closed -$951K – 4104
2022
Q1 		$951K Buy
50,288
+4,351
+9% +$111K ﹤0.01% 2632
2021
Q4 		$1.61M Buy
45,937
+1,429
+3% +$46.4K ﹤0.01% 2318
2021
Q3 		$1.63M Buy
44,508
+4,021
+10% +$158K ﹤0.01% 2241
2021
Q2 		$1.59M Buy
40,487
+26,163
+183% +$756K ﹤0.01% 2262
2021
Q1 		$405K Buy
14,324
+1,293
+10% +$41.2K ﹤0.01% 3163
2020
Q4 		$417K Buy
13,031
+893
+7% +$27.5K ﹤0.01% 2931
2020
Q3 		$392K Buy
12,138
+1,191
+11% +$37.1K ﹤0.01% 2792
2020
Q2 		$302K Buy
+10,947
New +$237K ﹤0.01% 2924

Other funds holding HCM

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Raymond James & Associates's HCM Position: Q2 2022 in Review

Raymond James & Associates sold out of HUTCHMED (HCM) in Q2 2022, closing a stake of 50,288 shares — an estimated $951K sold.

Raymond James & Associates first reported a position in HCM in Q2 2020 and held it in 8 quarters. The position peaked at $1.63M in Q3 2021. 116 funds tracked by Wall St. Rank hold HCM as of Q2 2022.

  • Raymond James & Associates reported no remaining HUTCHMED position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 50,288 HUTCHMED shares in Q2 2022, an estimated $951K.
  • Raymond James & Associates first reported a position in HUTCHMED in Q2 2020 and held it in 8 quarters.
  • Raymond James & Associates's HUTCHMED position peaked at $1.63M in Q3 2021.
  • 116 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.